Cprp - An unusual, repetitive protein which impacts pleuromutilin biosynthesis in the basidiomycete Clitopilus passeckerianus by De Mattos-Shipley, Kate M J et al.
                          De Mattos-Shipley, K. M. J., Foster, G. D., & Bailey, A. M. (2021).
Cprp - An unusual, repetitive protein which impacts pleuromutilin
biosynthesis in the basidiomycete Clitopilus passeckerianus. Frontiers
in Fungal Biology, 2, [655323].
https://doi.org/10.3389/ffunb.2021.655323
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.3389/ffunb.2021.655323
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Frontiers Media at
https://www.frontiersin.org/articles/10.3389/ffunb.2021.655323/full . Please refer to any applicable terms of use
of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the
published version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/
ORIGINAL RESEARCH
published: 06 April 2021
doi: 10.3389/ffunb.2021.655323







Ruhr University Bochum, Germany
Daren W. Brown,
United States Department of
Agriculture, United States
Lena Studt,
University of Natural Resources and
Life Sciences Vienna, Austria
*Correspondence:





This article was submitted to
Fungal Secondary Metabolites and
Mycotoxins,
a section of the journal
Frontiers in Fungal Biology
Received: 18 January 2021
Accepted: 04 March 2021
Published: 06 April 2021
Citation:
de Mattos-Shipley KMJ, Foster GD
and Bailey AM (2021) Cprp—An
Unusual, Repetitive Protein Which
Impacts Pleuromutilin Biosynthesis in
the Basidiomycete Clitopilus
passeckerianus.
Front. Fungal Biol. 2:655323.
doi: 10.3389/ffunb.2021.655323
Cprp—An Unusual, Repetitive Protein
Which Impacts Pleuromutilin
Biosynthesis in the Basidiomycete
Clitopilus passeckerianus
Kate M. J. de Mattos-Shipley*, Gary D. Foster and Andy M. Bailey*
School of Biological Sciences, University of Bristol, Bristol, United Kingdom
Interrogation of an EST database for Clitopilus passeckerianus identified a putative
homolog to the unusual stress response gene from yeast; ddr48, as being upregulated
under pleuromutilin production conditions. Silencing of this gene, named cprp, produced
a population of transformants which demonstrated significantly reduced pleuromutilin
production. Attempts to complement a Saccharomyces cerevisiae ddr48 mutant strain
(strain Y16748) with cprp were hampered by the lack of a clearly identifiable mutant
phenotype, but interestingly, overexpression of either ddr48 or cprp in S. cerevisiae
Y16748 led to a conspicuous and comparable reduction in growth rate. This observation,
combined with the known role of DDR48 proteins from a range of fungal species in
nutrient starvation and stress responses, raises the possibility that this family of proteins
plays a role in triggering oligotrophic growth. Localization studies via the production
of a Cprp:GFP fusion protein in C. passeckerianus showed clear localization adjacent
to the hyphal septa and, to a lesser extent, cell walls, which is consistent with the
identification of DDR48 as a cell wall-associated protein in various yeast species. To
our knowledge this is the first study demonstrating that a DDR48-like protein plays a role
in the regulation of a secondary metabolite, and represents the first DDR48-like protein
from a basidiomycete. Potential homologs can be identified across much of the Dikarya,
suggesting that this unusual protein may play a central role in regulating both primary
and secondary metabolism in fungi.
Keywords: pleuromutilin, secondary metabolism, CPRP, DDR48, Clitopilus passeckerianus, basidiomycete,
antibiotic
INTRODUCTION
An increasingly valuable class of compounds for human therapeutics are the semi-
synthetic pleuromutilin antibiotics (Figure 1). These compounds are all derived
from a tricyclic diterpene natural product called pleuromutilin, which is produced
by Clitopilus passeckerianus and related basidiomycete fungi (Hartley et al., 2009).
Tiamulin and valnemulin (Figure 1) have been used in veterinary medicine for many
years (Poulsen et al., 2001), but an increasing need for new antibiotics—largely due
to the emergence of antibiotic resistant strains in community situations—has led to
a surge in the development of pleuromutilin derivatives specifically for human use
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(Brooks et al., 2001; Bacqué et al., 2002; Springer et al., 2003;
Hirokawa et al., 2009; Wang et al., 2012; Shang et al., 2013, 2014;
Gao et al., 2017; Mu et al., 2017; Jin et al., 2019; Fan et al., 2020;
Xie et al., 2020; Zhang et al., 2020). To date, two pleuromutilin
antibiotics, retapamulin and lefamulin (Figure 1), have approval
for use in human therapeutics (Butler, 2008; Lodise et al., 2020),
and the development of further derivatives is ongoing, with
the extended spectrum pleuromutilins (ESPs) showing promise
against the difficult to treat Gram-negative bacteria (Paukner
et al., 2013a,b, 2015a,b; Wicha et al., 2015; Thirring et al.,
2017). There are also indications that pleuromutilins have the
potential to be developed into much needed anti-tuberculosis
agents (Lemieux et al., 2018).
The value of the pleuromutilins lies partly in their unique
mode-of-action; inhibiting bacterial protein synthesis by
selectively binding to conserved targets within the 50S ribosomal
subunit (Hodgin and Högenauer, 1974, Schlünzen et al., 2004,
Yan et al., 2006, Davidovich et al., 2007). This means that
pleuromutilins are associated with low rates of resistance
development and display minimal cross-resistance (Paukner
and Riedl, 2017). Exciting recent work has also shown that
pleuromutilin derivatives may have applications beyond their
utility as antibiotic agents, with one highly derivatised compound
named ferroptocide (Figure 1) exhibiting antitumour and
immunomodulatory activities (Llabani et al., 2019).
The increasing importance of the pleuromutilins has naturally
led to interest in both pleuromutilin biosynthesis and the biology
of the producing species (de Mattos-Shipley et al., 2017). In
the last 5 years, publications have reported the identification
of the pleuromutilin biosynthetic gene cluster (BGC) from
both C. passeckerianus (Bailey et al., 2016) and C. pseudo-
pinsitus (Yamane et al., 2017), elucidation of the biosynthetic
pathway via heterologous production of pleuromutilin, and
the generation of novel derivatives via the biotransformation
FIGURE 1 | The structures of pleuromutilin and various pleuromutilin derivatives. Valnemulin and tiamulin are used in veterinary medicine as antibiotic agents.
Retapamulin and Lefamulin both have approval for use in human medicine, as topical and oral / intravenous antibiotics, respectively. Ferroptocide is a recently
produced antitumour derivative, which triggers ferroptosis via the inhibition of thioredoxin.
of semi-synthetic pathway intermediates (Alberti et al., 2017).
What is currently poorly understood is the regulation of the
biosynthetic pathway, particularly in terms of which genes and
regulatory networks impact pleuromutilin production. Unlike
many fungal natural products, the pleuromutilin BGC contains
no pathway-specific regulatory genes (Bailey et al., 2016). It is
possible that pathway specific transcription factors are located
elsewhere in the genome, but it is also likely that biosynthesis is
under the control of complex global regulatory networks, as seen
in the regulation of gibberellin biosynthesis (Tudzynski, 2005).
An understanding of pleuromutilin regulation could help inform
strain improvement, which would in turn aid the development
of the pleuromutilins as affordable mass market compounds,
their expense currently being one of the major barriers to their
widespread use (Watkins and File, 2020). Previous attempts at
strain improvement have combined mutagenesis with media
optimisation, but this has been met with limited success (Papa
et al., 2006). In an attempt to gain insight into the regulation
of pleuromutilin from a genetic perspective, an internal EST
(Expressed Sequence Tag) database for C. passeckerianus, which
was generated under differential pleuromutilin production and
non-production conditions, was interrogated, and candidate
genes of interest were identified.
We now report investigations into one such identified gene,
which encodes an unusually repetitive protein we have named
Cprp (Clitopilus passeckerianus repetitive protein). Silencing
of cprp has shown that it does indeed impact pleuromutilin
biosynthesis, and localization studies have shown that Cprp
accumulates adjacent to the septa and, to a lesser extent, the
cell wall. A bioinformatic analysis has revealed that putative
homologs, all containing a repetitive S-Y-G motif that may be
involved in RNA binding, are frequent within the higher fungi,
suggesting that they may play a conserved role across a range of
fungal taxa.
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RESULTS
Initial Identification and Analysis of cprp
An internal EST database, containing libraries generated under
pleuromutilin production and non-production conditions,
was interrogated for candidate genes involved in the
regulation of pleuromutilin. A requirement for differential
expression was combined with specific search terms, based on
knowledge concerning the environmental factors which impact
pleuromutilin biosynthesis. One parameter used was homology
to genes involved in nitrogen regulation, due to observed
repression of pleuromutilin production upon the addition
of sodium nitrate or glutamic acid to the culturing medium
(Supplementary Figure 1). This identified EST contig c456
(accession number MW509766), which is upregulated during
pleuromutilin production (eight representative EST sequences in
the production library vs. one sequence in the non-production
library) and has homology with gsr1, which encodes a putative
nitrogen starvation response protein from Fusarium fujikuroi.
An alignment of the EST sequence with a genomic
database for C. passeckerianus (Bailey et al., 2016) confirmed
that c456 represents an entire coding sequence and allowed
the identification of three introns, all with the GT-AG
splice-site consensus. Translation to the predicted protein
revealed a highly repetitive amino acid sequence, and thus
the protein was named Cprp (C. passeckerianus repetitive
protein), with the encoding gene named cprp. Searching
the NCBI Swiss-Prot protein database with Cprp determined
that this protein shares significant sequence similarity (E
= 3 × 10−32; 59.9 % protein identity) with the stress
response protein DDR48 from S. cerevisiae (Accession number
P18899.4; Supplementary Figure 2). Both DDR48 and Cprp
are unusual proteins which are highly repetitive with low
amino acid sequence complexity, being enriched in asparagine,
serine, aspartic acid and glycine residues (Figure 2A). DDR48
consists largely of eight amino acid repeats with the sequence
NNXDSYGS or similar. Cprp, although less consistently
repetitive, contains multiple copies of a similar motif with the
same core S-Y-G-S sequence (Figure 2A). Motifs containing S-
Y-G are best known for their roles in RNA binding (Mitsuhashi
et al., 2017), which could potentially indicate a role for these
genes in RNA-mediated regulation. As RNA binding proteins
are commonly composed of prion-like domains (PrLDs) (March
et al., 2016), a PLAAC analysis, which scans protein sequences
for domains with prion-like amino acid composition was
conducted (Lancaster et al., 2014). This determined that both
DDR48 and Cprp are comprised largely of prion-like amino
acid domains (Figure 2B; Supplementary Figures 3, 4). Finally,
an NCBI conserved domain search (Lu et al., 2020) provided
evidence that DDR48 and Cprp contain a PTZ00110 super family
helicase domain (accession: cl36512; DDR48: E = 9.12 × 10−04;
Cprp: E= 7.92× 10−04).
Silencing of cprp Reduces Antibiotic
Production
To experimentally probe any relationship between Cprp and
pleuromutilin biosynthesis a plasmid containing a cprp antisense
(cprp-AS) cassette was constructed. Gene silencing using such
an approach has previously been successfully employed for
C. passeckerianus and aided the original identification of
the pleuromutilin gene cluster (Bailey et al., 2016). Sixty
resulting C. passeckerianus cprp-AS (antisense) transformants
were subjected to an initial analysis of pleuromutilin production
via plate-based bioassay (Figures 3A–C).
A clear reduction in B. subtilis inhibition, as measured
by clearing zone diameter, was observed for many of the
antisense transformants, with three transformants demonstrating
no antibacterial activity at all (Figure 3A). The average clearing
zone diameter was 70.0% of the wild type with the colony
size ranging from 76.1 to 129% of the wild type with an
average of 112.4% (Figure 3B; Supplementary Figure 5). A
control set of transformants was generated using the original
pYES-hph-CBXgene plasmid (Bailey et al., 2016) without the
cprp antisense cassette. Although these control transformants
demonstrated some variation in clearing zone diameter, any
change could be accounted for by a comparable increase
or decrease in growth rate, as demonstrated by a linear
relationship between colony diameter and clearing zone diameter
(Figure 3C; Supplementary Figure 5). Across the set of control
transformants, the average colony diameter was 105.7% of wild-
type and the average clearing zone was 100.8% of wild-type.
Cprp-AS transformants 5, 7, 8, 9, 12, 17, 21, 35, 43, and 58,
which produced clearing zones of varying sizes, were subjected
to further analysis. Diagnostic PCRs confirmed integration of the
silencing cassette (Supplementary Figure 10) and northern blot
analysis confirmed clear, albeit varying, silencing of cprp in all
lines screened (Supplementary Figure 6). Fermentation in liquid
production medium (CGC), chemical extraction and HPLC
analysis confirmed that although all transformants produced
some pleuromutilin, many demonstrated significantly reduced
titres in liquid cultures, and these reductions were in agreement
with the bioassay data (Figure 3D).
Expression of cprp in an S. cerevisiae
ddr48 Mutant
To investigate whether Cprp is a true functional homolog of
DDR48 from S. cerevisiae, complementation of a ddr48 mutant
strain (strain Y16758) with cprp was attempted. A series of
plasmids were constructed to allow expression of cprp in strain
Y16758. All constructs were built using the yeast expression
vector pYES2-19, placing expression under the control of the
strongly inducible pGAL1 promoter (West et al., 1984). All
constructs were designed to include 20 bp of the 5′ UTR from
ddr48, because in S. cerevisiae, this region of the 5′ UTR often
contains a consensus sequence which improves the efficiency
of transcription. This consensus sequence was then followed
by either the cprp coding sequence (plasmid pYES2-CpcDNA)
or the full gene including the three introns (plasmid pYES2-
CpgDNA). The genomic construct was used as a negative control,
to confirm that any phenotypes observed are due to the correct
translation of Cprp. As a positive control, a construct was built
containing the wild-type DDR48 gene (plasmid pYES2-DDR48).
The three constructs were transformed into the ddr48 mutant
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FIGURE 2 | (A) Both DDR48 and Cprp are shown to be highly repetitive proteins with low amino acid sequence complexity, being enriched in asparagine, serine,
aspartic acid, and glycine residues. Both contain multiple [G/S]-Y-[G/S] motifs (in red), which are known to be present in intrinsically disordered RNA-binding proteins.
(B) A PLAAC analysis of Cprp and DDR48 showing regions (framed in red) which are predicted to be prion-like domains (Lancaster et al., 2014).
strain Y16758. In addition, pYES2-19 (lacking any insert) was
transformed into both the ddr48mutant and the wild-type strain
Y10000 as negative controls and to allow direct comparison with
the various transformants on media lacking uracil.
The ddr48 mutant Y16758 and parental strain Y10000 were
subjected to a variety of examinations in an attempt to show
a clear mutant phenotype, thus allowing any complementation
to be assessed. A slight decrease in tolerance to heat-shock
treatments had previously been reported in a ddr48 mutant
(Treger and McEntee, 1990), but unfortunately no difference
could be detected between Y16758 and Y10000. Ddr48 mutants
were also reported to exhibit reduced spontaneous mutation
rates, as measured by spontaneous resistance to canavanine or
reversion to histidine prototrophy. Replicating the exact method
used by Treger and McEntee (1990) failed to generate any
canavanine resistance in either strain, even when 50 times the
number of cells were plated out, and it was not possible to test
mutation rates at the his3 locus as the strains used in this work
are his3 deletion strains.
Another reported phenotype for ddr48 mutants is an
increased sensitivity to salt stress (Yoshikawa et al., 2009).
In an attempt to reproduce this finding, agar spotting assays
were conducted, but as is apparent in Figure 4A, there was
no discernible difference in the growth of the wild-type strain
(Y10000) or the ddr48 mutant (Y16758). Growth rates were
then measured in liquid cultures to more accurately assess
any differences. A small but significant difference was observed
at 0.3 and 0.5M NaCl, with the ddr48 mutant appearing to
have a slightly higher tolerance to osmotic stress than the
wild-type strain (Figure 4B), which directly contradicts the
previous findings.
Transformants containing the various cprp or ddr48
expression constructs were subjected to similar screening in
media supplemented with NaCl, but unfortunately no consistent
pattern could be detected (Figure 5A). However, an unexpected
consequence of overexpression of either DDR48 or Cprp was
a clear and significant reduction in growth rate (Figure 5B).
The average growth rate of mutant Y16748(+ura3) was slightly
higher than the parental strain Y10000(+ura3), whereas the
DDR48 overexpression transformants showed a striking decrease
in growth rate when grown in cultures containing galactose (to
induce expression), with an average optical density of only 37.2%
of wild-type and 32.0% of the ddr48 mutant. The yeast strains
complemented with a C. passeckerianus cprp cDNA cassette
showed a similar reduction in growth rate, being 44.3% of wild-
type and 38.0% of the ddr48mutant (Figure 5B). Transformants
containing a cprp cassette constructed using genomic DNA,
which would not produce a functional protein in S. cerevisiae,
did not show any reduction in growth rate, either in the presence
or absence of galactose induction.
Localization of Cprp in C. passeckerianus
To investigate whether Cprp is localized to a particular
subcellular region, a Cprp-GFP fusion protein was expressed
in C. passeckerianus. A genomic fragment comprising the cprp
promoter and coding region was fused with eGFP using yeast
homologous recombination, replacing the stop codon of cprp
with the start codon of GFP. The resulting plasmid, pYES-hph-
cprpGFP, was transformed into C. passeckerianus, generating
seven independent transformants. Two of these; Cprp-GFP-2 and
Cprp-GFP-5, were found to fluoresce during initial screens so
were prepared for confocal microscopy by growing mycelium
across a sterilized microscope slide. A C. passeckerianus line
expressing GFP under the control of PgpdII on the plasmid
p004iGM3 (Burns et al., 2005) was used as a negative control
to confirm that GFP is not normally subject to localization in C.
passeckerianus. Confocal microscopy confirmed that wild-typeC.
passeckerianus exhibits no detectable fluorescence (Figure 6A),
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FIGURE 3 | Analysis of pleuromutilin production in a population of cprp-AS (antisense) transformants. (A) Bioassay plates for wild-type C. passeckerianus and
cprp-AS transformants 17, 35, and 58 (left to right). (B) Bioassay data for a population of 60 cprp-AS transformants. Full bioassay data for each transformant can be
seen in Supplementary Figure 5. (C) Bioassay data for a population of 53 control transformants containing plasmid pYES-hph-CBXgene. Full bioassay data for
each transformant can be seen in Supplementary Figure 5. (D) HPLC and plate-based analysis of pleuromutilin production for wild-type C. passeckerianus and
selected cprp-AS transformants. Transformants 17, 35, and 58 produced no observable clearing zone beyond the edge of the colony; what is seen here is the colony
diameter. Error bars represent the standard deviation of triplicate measurements. * denotes HPLC data which was found to be significantly different to the wild-type
data (as determined by a two-tailed t-test. See Supplementary Table 1 for P-values).
whereas the strain expressing GFP from plasmid p004iGM3
exhibited cytoplasmic fluorescence with no particular localisation
(Figure 6B). Confocal images of the Cprp-GFP transgenic lines
showed clear evidence of localization, with fluorescence being
concentrated adjacent to the septa and a slight increase in
fluorescence at the periphery of the cell (Figure 6C).
Bioinformatic Analysis of the DDR48/Cprp
Family
The presence of a likely DDR48 homolog in Clitopilus
passeckerianus, as well as the previously identified homologs in
Candida albicans andHistoplasma capsulatum raises the question
as to how widely distributed such proteins may be. To explore
this, the NCBI nr protein database was searched for similar
proteins (blastp algorithm; Expect threshold= 1× 10−05) within
the main fungal taxonomic divisions. Proteins demonstrating
significant similarity to DDR48 and Cprp were identified
within all subdivisions of the Basidiomycota (namely the
Agaricomycotina, Pucciniomycotina, and Ustilaginomycotina)
and within both the Saccharomycotina and Pezizomycotina
ascomycete subdivisions (Table 1; Supplementary Table 4,
Supplementary Figure 9). Interestingly, it was not possible to
detect any putative homologs within the Taphrinomycotina, a
monophyletic subdivision which is considered to be basal to
the rest of the Ascomycota (Sugiyama et al., 2006). No proteins
with significant sequence similarity with either Cprp or DDR48
from S. cerevisiae were identified within the Zygomycota,
Chytridiomycota, Glomeromycota, or Neocallimastigomycota.
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FIGURE 4 | (A) Agar spotting assays for salt tolerance of S. cerevisiae strain Y10000 and Y16748 showed no apparent difference. (B) The optical density (O.D) of
Y10000 and Y16748 (1ddr48) S. cerevisiae cultures 16 h after inoculation in media containing a range of NaCl concentrations. Error bars represent the standard
deviation of triplicates. * Denotes NaCl concentrations where the responses of Y10000 and Y16748 (1ddr48) were found to be significantly different (as determined
by a two-tailed t-test. See Supplementary Table 2 for P-values).
FIGURE 5 | Analysis of S. cerevisiae strains Y10000 (“WT”) and Y16748 (1ddr48), as well as transformants highly expressing either DDR48 (+DDR48) or Cprp gDNA
(+Cp gDNA) or cDNA (+Cp cDNA). Two separate transformants were assessed for each construct (T1 and T2). Error bars represent the standard deviation of
triplicates. (A) Response to salt stress as measured by the O.D of cultures supplemented with 0.5M NaCl, compared to cultures not supplemented. (B) Growth rate
analysis, as measured by the O.D of cultures 16 h after inoculation. All cultures contained 20% (w/v) galactose to induce expression from the pGAL1 promoter.
* Denotes transformants which had growth rates that were significantly different to strain Y10000 (+pYES2) (as determined by a two-tailed t-test. See
Supplementary Table 3 for P-values).
One protein, accession number KNE54004.1, was identified
within the Blastocladiomycotina and although this protein
has relatively low similarity to DDR48 and Cprp (40.38 and
33.79% protein identity, respectively) it is similarly repetitive
and contains a very similar motif (S-Y-D-S-Y-G-Y). An
analysis of the predicted proteins found that although they
vary quite significantly in length, they are all enriched in
serine, asparagine, aspartic acid and glycine, and have a low
negative GRAVY score (grand average of hydropathicity index),
implying that they are largely non-polar and hydrophobic
proteins (Supplementary Table 4). An analysis of the repetitive
motifs in these proteins show that they all contain a core
G/S-Y-G/S sequence, with S-Y-G being the dominant motif (See
Supplementary Figure 9 for representative sequence logos).
Although not identified through blast analysis, a literature
search for any proteins with an S-Y-G motif rapidly identified
a family of RNA-binding proteins from humans which are
components of RNA granules and which are implicated in a
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FIGURE 6 | Cprp localization in C. passeckerianus. (A) Wild-type C.
passeckerianus. (B) C. passeckerianus expressing GFP from plasmid
p004iGM3, showing dispersal throughout the hyphae. (C) C. passeckerianus
expressing a Cprp-GFP fusion protein, showing clear septal localization and
increased fluorescence at the cell wall. Each image shows a phase contrast
image, a fluorescent image and a merged image (left to right).
spectrum of diseases (Mitsuhashi et al., 2017). These proteins
are characterized by multiple copies of a (G/S-Y-G/S)-motif
that has been identified as an RNA-binding site (Castello
et al., 2016), are low-complexity (Kato et al., 2012) and
are typically enriched in glutamine, and/or asparagine. Thus,
although they have relatively low sequence similarity with
DDR48 and Cprp, they share certain unusual characteristics.
Three of these proteins; FUS, TAF15, and EWSR1 were included
in this analysis and can be seen summarized in Table 1 and
Supplementary Table 4. Their protein identities with Cprp and
DDR48 ranged from 29.3 to 33.5%, and unlike the fungal
proteins which contain almost exclusively S-Y-G motifs, the
proteins from Homo sapiens include the full range of (G/S-
Y-G/S) RNA binging motifs; namely S-Y-S, S-Y-G, G-Y-S,
and G-Y-G (Supplementary Table 4, Supplementary Figure 9).
Furthermore, the amino acids surrounding the core sequence
vary far more, as can be seen in the sequence logos generated for
these proteins (Supplementary Figure 9B).
Another feature that the fungal proteins share with the
human RNA-binding proteins is that they are all predicted
to be intrinsically disordered proteins (as analyzed by
InterPro), which are characterized by a lack of defined
three-dimensional structure.
DISCUSSION
To gain an insight into how pleuromutilin biosynthesis is
regulated, a C. passeckerianus EST (Expressed Sequence Tag)
database, containing libraries generated under production and
non-production conditions, was searched for any sequences
likely to impact pleuromutilin production. As pleuromutilin
biosynthesis is repressed by the addition of nitrogenous
compounds such as glutamic acid (Supplementary Figure 1), the
libraries were specifically searched for sequences demonstrating
similarity with genes involved in nitrogen regulation. Contig_456
(c456) was highlighted due to clear differential representation
in pleuromutilin production and non-production libraries and
sequence similarity to gsr1 from Fusarium fujikuroi, a gene
known to be strongly upregulated under nitrogen starvation
conditions (Teichert et al., 2004, Teichert et al., 2006).
Annotation of the gene represented by EST c456 determined
that it encodes a highly repetitive protein (named Cprp: C.
passeckerianus repetitive protein), with low sequence complexity
and significant similarity (59.9% identity) with the stress-
response protein DDR48. DDR48, originally identified in S.
cerevisiae, has also been identified and investigated in Candida
albicans and Histoplasma capsulatum. It has been shown to
respond to a wide range of environmental stresses, including
exposure to DNA damaging chemicals, heat-shock, osmotic
stress, oxidative stress, DNA replication stress and exposure
to antifungals (McClanahan and McEntee, 1986; Treger and
McEntee, 1990; Miralles and Serrano, 1995; Karababa et al., 2004;
Hromatka et al., 2005; Setiadi et al., 2006; Hao et al., 2009;
Tkach et al., 2012; Mostafa and Awad, 2015). A recent study
found that in H. capsulatum DDR48 confers some resistance
to the antifungal azoles via the regulation of sterol biosynthesis
(Reyes, 2019; Blancett et al., 2020), which is consistent with
an increase in ddr48 expression in azole-resistant isolates of
C. albicans (Mostafa and Awad, 2015). DDR48 is also known
to be required for H. capsulatum pathogenicity and survival
in macrophages, likely due a role regulating the enzymes
needed to detoxify reactive oxygen species (ROS) (Blancett,
2019; Blancett et al., 2020). Regulating complex pathways in
response to environmental factors is perfectly consistent with a
potential role in the regulation of secondary metabolites such as
pleuromutulin, which are known to be produced under specific
environmental conditions.
Silencing of cprp via the expression of an antisense construct
generated a population of C. passeckerianus transformants
exhibiting a pronounced reduction in pleuromutilin production,
demonstrating that Cprp does indeed impact pleuromutilin
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TABLE 1 | Representative DDR48-like proteins identified across the higher fungi.
Species Accession number [G/S]Y[G/S] motif PI with Cprp (%) PI with DDR48 (%)
SYG SYS GYS GYG
Ascomycota
Pezizomycotina
Fusarium fujikuroi XP_023428359.1 18 0 0 0 64.45 55.93
Histoplasma capsulatum EER43993.1 16 1 0 0 42.54 56.16
Talaromyces verruculosus KUL83446.1 26 0 0 0 68.50 72.77
Colletotrichum tropicale KAF4827718.1 21 0 0 1 46.25 60.18
Aspergillus oryzae EIT81464.1 23 0 0 1 51.16 55.00
Saccharomycotina
Saccharomyces cerevisiae P18899.4 39 0 0 0 59.55 –
Candida albicans XP_714253.1 19 0 0 0 75.27 67.06
Zygotorulaspora mrakii QLG71076.1 45 0 0 0 60.00 65.95
Naumovozyma dairenensis XP_003671904.1 35 1 0 52.38 66.39
Basidiomycota
Agaricomycotina
Clitopilus passeckerianus – 17 1 0 0 – 59.55
Coprinopsis cinerea XP_001835064.1 14 2 0 2 47.39 44.40
Heterobasidion irregular XP_009552756.1 12 0 0 1 46.38 41.49
Trametes versicolor XP_008040989.1 14 0 0 2 54.55 49.13
Stereum hirsutum XP_007311260.1 14 0 0 1 52.24 44.20
Ustilaginomycotina
Testicularia cyperi PWY96941.1 20 0 0 0 64.00 56.62
Violaceomyces palustris PWN49054.1 14 1 0 0 45.78 49.38
Pucciniomycotina
Microbotryum silenes-dioicae SGZ21624.1 6 1 0 2 32.56 40.96
Blastocladiomycota
Allomyces macrogynus KNE54004.1 15 0 0 13 33.79 40.38
Homo sapiens FUS sp|P3563| 7 3 2 9 23.91 31.72
Homo sapiens TAF15 sp|Q92804| 4 4 3 23 31.85 33.50
PI, Protein identity. See Supplementary Table 1 for additional sequences and further information regarding protein length, composition and GRAVY scores. These proteins share
certain characteristics with a family of human RNA binding proteins, two of which (FUS and TAF15) are shown here.
biosynthesis. The variation in phenotypes observed is typical
for antisense silencing, as the extent of silencing is impacted by
many factors including the integration site and copy number of
the silencing cassette. The transformation technique used in this
work is known to result in multiple random integration events
in C. passeckerianus (Kilaru et al., 2009), which may account
for the observed variation in pleuromutilin titres. HPLC analysis
confirmed a reduction in yield that was consistent with the
bioassay results, providing further confidence that the observed
impact on pleuromutilin production is genuine.
Attempts to complement an S. cerevisiae ddr48mutant (strain
Y16748), as a means of investigating functional homology, were
hampered by the lack of a clear mutant phenotype. No difference
could be detected between the mutant and wild-type in terms of
heat-shock response, and no spontaneous canavanine resistance
was observed, removing it as amethod ofmeasuring spontaneous
mutation rates. Since the initial report that DDR48 is involved
in spontaneous mutation rates (Treger and McEntee, 1990), a
subsequent study failed to detect any such phenotype despite
testing multiple loci and conducting sequencing analysis (Roche
et al., 1995), so this potential phenotype was not pursued further.
The previous reports of increased sensitivity to osmotic stress
(Yoshikawa et al., 2009) could also not be replicated in this study.
One unexpected finding from this work was the impact of
DDR48 and Cprp on growth rates. The S. cerevisiae ddr48
mutant appeared to have a slightly increased growth rate, and
although this difference was small, it is consistent with previous
findings. Breslow et al. (2008) developed a highly sensitive
method for testing competitive fitness in S. cerevisiae and of 4,204
deletion strains tested, 45% had observable growth defects but
only a few strains, including a ddr48 mutant, exhibited a slight
growth advantage. Breslow and colleagues observed that many
of the strains found to have an increased growth rate contained
mutations in genes involved in nutrient-signaling pathways,
suggesting that they may help to regulate or limit growth
when resources are limited to minimize resource depletion
(Breslow et al., 2008). Consistent with the increase in growth
rate upon deletion of ddr48 in S. cerevisiae is an increase in
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colony size seen for many cprp-AS transformants, which had
an average colony diameter of 112.4% of wild-type, with one
strain recording a colony diameter that was 129% of wild-type.
Conversely, when either DDR48 or Cprp were highly expressed
in S. cerevisiae strain Y16748, a dramatic decrease in growth
rate of ∼60% was observed. If DDR48 is involved in nutrient
signaling, overexpression may be expected to cause the yeast cells
to enter the stationary phase, which is characterized by cell cycle
arrest and normally occurs when available nutrients have been
exhausted (Werner-Washburne et al., 1993).
Although no studies have specifically investigated a role for
DDR48 homologs in nutrient signaling, there is significant data
which supports this supposition.Ddr48 expression is impacted by
a number of regulators involved in nutrient signaling including
AFT1 (iron deprivation); CST6 (non-optimal carbon source
utilization) and MIG1 (glucose repression) (Hu et al., 2007).
Searching the Expression Atlas database (Papatheodorou et al.,
2018) reveals that ddr48 is also downregulated in ura2 and gln3
deletion mutants; Ure2 and Gln3 both being key regulators in
nitrogen catabolite repression. Ddr48 has also been shown to be
upregulated in a S. cerevisiae gis1 mutant strain (Zhang et al.,
2009); Gis1 being a transcription factor which is thought to
be involved in shift from exponential growth to the stationary
phase in response to nutrient availability. In line with this,
Kusch et al. (2008) identified DDR48 as being one of the 50
most abundant proteins during stationary growth in C. albicans.
In filamentous fungi, the link between secondary metabolism
and the stationary phase has been so well-established that the
stationary phase has been described as “the secondary metabolite
producing growth phase” (Keller, 2019). The identification of
cprp as being upregulated during pleuromutilin production
may suggest that under production conditions, cultures of C.
passeckerianus enter into the stationary phase, although this has
not been explicitly tested. Cprp playing a role in coordinating
entry into the stationary phase with the regulation of processes
such as secondary metabolism is one plausible explanation for
the impact of cprp downregulation on both growth rate and
pleuromutilin biosynthesis.
In different fungal species, DDR48 has been reported
as both a cell wall protein (Tonouchi et al., 1994) and
as being localized to the cytoplasm (Huh et al., 2003).
To investigate the localization of Cprp, a Cprp-GFP fusion
protein, consisting of the full Cprp peptide fused to GFP, was
successfully expressed in C. passeckerianus. Confocal microscopy
provided clear evidence of localization adjacent to the septa
with some increased fluorescence observed at the periphery
of the cell. The localization appears to be asymmetrical,
differing on either side of the septa, with a pattern which is
intriguingly reminiscent of subcellular compartments formed
due to cytoplasmic streaming in filamentous fungi (Pieuchot
et al., 2015) (Supplementary Figure 8). There is precedent for
fungal proteins involved in stress responses localizing to the
septa in filamentous fungi. AoSO, a protein from Aspergillus
oryzae was found to be dispersed throughout the cytoplasm
under normal growth conditions but quickly localized to the
septa following various stresses, including extreme temperatures,
very acidic or alkaline pH, nitrogen and carbon depletion and
physical depletion (Maruyama et al., 2010). AoSO is now known
to be a component of stress granules in A. oryzae (Huang et al.,
2013), which are non–membrane-bound assemblies of protein
and RNA (known as messenger ribonucleoproteins; mRNPs) that
form in response to a variety of environmental stresses and which
regulate gene expression.
Finally, we have established that DDR48 and Cprp belong to
a family of similar repetitive proteins encoded by much of the
higher fungi. These proteins all contain a repetitive motif with a
putative RNA binding sequence (S-Y-G) and are predicted to be
intrinsically disordered proteins (IDPs) which contain prion-like
domains (PrLDs). IDPs play various cellular roles including in
transcriptional regulation, where their specific function is aided
by their conformational flexibility. Not only are IDPs known to
play an important role in interactions with nucleic acids, but
intrinsically disordered sequences have recently been reported
as important drivers of liquid-liquid phase separation (LLPS),
a feature required for the formation of RNA granules such as
stress granules. Aromatic residues such as tyrosine, which is
at the core of the repetitive motif of all Cprp-like proteins,
are thought to be particularly important for LLPS (Lin et al.,
2017). The S-Y-G motif provides another tentative link to RNA
granules, as a similar motif has been characterized in a family
of RNA-binding proteins from humans which are known to be
components of RNA granules and which are implicated in a
spectrum of diseases (Mitsuhashi et al., 2017). A potential role
for DDR48 proteins in RNA-mediated regulation is consistent
with a study which found that DDR48 overexpression in S.
cerevisiae resulted in a 63% decrease in RNA accumulation (Li
et al., 2008). Additionally, Cprp and DDR48 both contain a
PTZ00110 helicase domain, a domain seen in DEAD-box ATP-
dependent RNA helicases. Members of this enzyme family are
known to participate in every aspect of RNAmetabolism (Cordin
et al., 2006), and are known to localize to RNA granules (Hilliker,
2012). Although entirely speculative at this point, notional ATP-
dependent RNA helicase activity is consistent with the previous
finding that DDR48 from S. cerevisiae exhibits ATP hydrolysis
in vitro (Sheng and Schuster, 1993).
CONCLUSION
Cprp is an unusual repetitive protein which is abundantly
expressed under pleuromutilin production conditions, contains
multiple copies of a (N/D)(N/D)(N/D)SYGS motif, and which
shares significant sequence similarity with the stress-response
protein DDR48 from yeast. Silencing of cprp confirmed that
this protein impacts pleuromutilin biosynthesis, and localization
studies showed clear accumulation of Cprp adjacent to the septa.
Although complementation of a ddr48 mutant was hampered
by the inability to reproduce previously reported mutant
phenotypes, DDR48 and Cprp caused a clear and identical
overexpression phenotype, namely a reduction in growth rate
of ∼60%. This phenotype is compatible with previous evidence
for a role in nutrient signaling, a role which could logically
align with a protein having an impact on both growth rates
and secondary metabolite (SM) biosynthesis—SM biosynthesis
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being known to be frequently regulated by nutrient availability,
and in particular entry into the stationary growth phase. A
bioinformatic analysis of DDR48 and Cprp predicted that they
are both intrinsically disordered proteins, consisting mostly of
prion-like domains (PrLDs), two features commonly seen in
RNA binding proteins, and particularly in proteins involved in
the formation of RNA granules. They also share a core [G/S]-
Y-[G/S] motif with a family of RNA-binding proteins from
humans. As a family of fungal proteins which appear to regulate
both primary and secondary metabolism in response to a wide
range of environmental factors, DDR48 and Cprp-like proteins
undoubtably warrant further investigation.
MATERIALS AND METHODS
Fungal Strains and Growth Conditions
Clitopilus passeckerianus strain DSMZ1602 was used throughout
these experiments. This strain was maintained at 25◦C on Potato
Dextrose Agar (PDA 24 g/L potato dextrose, 15 g/L agar). Potato
Dextrose Broth (PDB: 24 g/L potato dextrose) was used for
making C. passeckerianus glycerol stocks.
Saccharomyces cerevisiae strain BY4742 (MATα, his31-1,
leu21-0, lys21-0, ura31-0) (Brachmann et al., 1998) was used
for all yeast recombinations and as the “wild-type” strain in
complementation studies, along with a mutant S. cerevisiae
strain (BY4742, YMR173w::kanMX4) which was obtained from
EUROSCARF (Accession number: Y16748). Bacillus subtilis
strain ATCC 6633 was used for all plate-based bioassays for
antibiotic activity. For cloning, chemically competent cells were
prepared using DH5αTM E. coli cells.
Media
C. passeckerianus
All cultures of C. passeckerianus were incubated at 25◦C, with
liquid cultures grown with shaking at 230 rpm. CSO1-A (4
ml/L rape seed oil, 50 g/L glucose, 12.5 g/L yeast extract, 1.0
g/L KH2PO4, 0.5 g/L MgSO4.7H2O, 0.7 g/L Ca(N03)2.4H2O, 0.1
g/L NaCl, 0.05 g/L FeSO4.7H2O; pH 6.2). C. passeckerianus was
grown in CSO1-A prior to transformation. PDAS (24 g/L potato
dextrose broth, 15 g/L agar, 205 g/L sucrose; pH 6.3) was used
as regeneration medium for C. passeckerianus protoplasts after
transformations. PVS (8 g/L rape seed oil, 35 g/L spray dried corn
liquor, 15 g/L glucose, 5 g/L calcium carbonate) was used as the
seed medium for HPLC analysis of C. passeckerianus. CGC (50
g/L glucose, 5 g/L spray dried corn steep liquor, 2 g/L calcium
carbonate) was used as the production media for HPLC analysis
of pleuromutilin production. Tryptic Soy Agar-b (TSAb: 30 g/L
tryptic soy broth, 20 g/L agar) was used as the base agar on which
to grow C. passeckerianus for pleuromutilin bioassays.
S. cerevisiae
S. cerevisiae was grown at 28◦C either on agar plates or in liquid
media shaking at 220 rpm.
YPDA (10 g/L yeast extract, 20 g/L peptone, 20 g/L D-glucose,
20 g/L agar) was used for growth andmaintenance of S. cerevisiae.
YPD (as above but without agar) was used for growth rate
assays for strains Y10000 and Y16748. Yeast Synthetic Drop-
Out Medium (YSDOM: 5 g/L casein hydrolysate, 6.7 g/L yeast
nitrogen base w/o amino acids, 20 mg/L adenine, 20 mg/L
tryptophan, 20 g/L agar, 100ml of sterile 20% glucose (w/v) added
after autoclaving) was the selective medium for S. cerevisiae
post transformation. Yeast Synthetic Drop-Out Medium-Gal
(YSDOM-G: 5 g/L casein hydrolysate, 6.7 g/L yeast nitrogen
base w/o amino acids, 20 mg/L adenine, 20 mg/L tryptophan,
20 g/L agar, 100ml of sterile 20% galactose (w/v) added after
autoclaving) was used for the analysis of S. cerevisiae strains
overexpressing either DDR48 or Cprp, as galactose induces
expression of the pGAL1 promoter.
E. coli
All E. coli strains used were grown at 37◦C on either solid
agar plates or in liquid media with shaking at 225 rpm. B.
subtilis was incubated at 30◦C either as an overlay (static) or
with shaking at 200 rpm. Luria-Bertani Broth (LB: 10 g/L
NaCl, 10 g/L tryptone, 5 g/L yeast extract, pH 7) and Luria-
Bertani Agar (LBA: LB supplemented with 15 g/L agar) were
used for standard propagation. Tryptic Soy Broth (TSB: 30 g/L
tryptic soy broth) was used to grow a B. subtilis culture for
the preparation of B. subtilis spores used in bioassays. Tryptic
Soy Agar-g (TSAg: 30 g/L tryptic soy broth, 5 g/L agar, 10
g/L glucose) was supplemented with 1 ml/L of Bacillus subtilis
spore suspension (∼4.5 × 109 spores/ml) and 7.5 ml/L of 4%
TTC (2,3,5-Triphenyl-2H-tetrazolium chloride) and used as the
overlay for bioassays.
Media Supplements
Hygromycin B (Duchefa) was added to either PDAS
(regeneration medium−600µg/ml overlay) or PDA
(maintenance medium−50µg/ml) to select for fungal
transformants. Ampicillin (Melford) was used to select for
E. coli transformants at a working concentration of 50 µg/ml.
PCR
Amplification of fragments for plasmid construction were carried
out using the proof-reading polymerase KAPA HiFi HotStart
(Roche). Analytical PCRs were performed using Biomix Red
(Bioline). Primers used in this study are listed in Table 2.
Restriction Enzyme Digests
Restriction enzyme digests were used to linearise plasmids
prior to yeast recombination and to analyse plasmids after
construction. All enzymes and buffers were purchased
from Thermo Scientific and used according to the
manufacturers’ instructions.
Ligations
Ligations were conducted using Quick-stick ligase from Bioline
and set up as follows: 4 x Quick-Stick Buffer (2.5 µl), T4 DNA
ligase (0.5 µl), linearised vector backbone (X µl), insert (X µl)
and water to 10 µl, with the backbone and insert added at a
molar ratio of 3:1 with a maximum total weight of 100 ng. The
ligation reactions were incubated at room temperature for 20
minutes before transforming the entire 10 µl into competent
E. coli (DH5-α).
Frontiers in Fungal Biology | www.frontiersin.org 10 April 2021 | Volume 2 | Article 655323
de Mattos-Shipley et al. Cprp From Clitopilus passeckerianus
























Compound primers with tails (in italics) were designed to allow for yeast recombination.
Introduced restriction sites are underlined. The sequence in lowercase in primer
HindIII_DDR48-cprpF is to introduce 20 bp of the DDR48 5′UTR to the amplified cprp
coding sequence.
Fungal DNA Preparation
DNA extractions for the purpose of fragment amplification for
building constructs and diagnostic PCR analysis were carried out
as described by Liu et al. (2000).
Fungal RNA Preparation
All RNA preparations were done using the RNeasy Mini
Kit (Qiagen) according to the manufacturer’s protocol. For
northern blot analysis, total RNA was extracted from 5-day
old C. passeckerianus mycelia grown in PDB using the RNeasy
Mini Kit (Qiagen) according to the manufacturer’s protocol. Gel
electrophoresis and spectrophotometric quantification were used
to check quality and to calculate RNA concentrations.
BIOINFORMATICS
Analysis of sequence chromatograms was conducted using
Sequencher 4.10.1. Protein alignments were conducted using
Clustal Omega (Sievers and Higgins, 2018). Blast2Go (Götz
et al., 2008) was used to conduct large-scale blast searches using
the blastx algorithm and automatically assign Gene Ontology
(GO) terms to the EST sequences. To identify putative Cprp
homologues the blastp algorithm (Altschul et al., 1990) was used
to interrogate the NCBI nr database. MEGA-X (Kumar et al.,
2018) was used to produce a phylogenetic tree of Cprp/DDR48-
like proteins using the neighbor-joining method, with bootstrap
test percentages of 1,000 replicates shown next to the branches.
To produce sequence logos, the online tool WebLogo was used
(Crooks et al., 2004).
Antibiotic Bioassays and HPLC Analysis
Plate-Based Bioassays
Fungal strains were point inoculated onto the center of a petri
dish containing 25ml of tryptic soy agar (TSA) and allowed
to grow for 5 days at 25◦C. Bioassays were then conducted as
previously described (Hartley et al., 2009).
HPLC Analysis
C. passeckerianus was grown in 50ml CGC at 25◦C with 230
rpm shaking for 5 days. Mycelia was then homogenized for 3min
using a polytron homogeniser. 3ml of acetonitrile was added to
1ml of homogenized culture and shaken for 15min (1,000 rpm).
1ml of sample was then centrifuged at 16,000 × g for 10min to
pellet particulate matter and the supernatant was collected for
HPLC analysis.
Pleuromutilin titer was calculated using the HP1050 HPLC
system fitted with a 260 × 4.6mm C18 column and a C18 guard
column. The mobile phase used was 55% acetonitrile with a
flow rate of 1 ml/min and a column temperature of 30◦C. The
absorbance was measured at a wavelength of 205 nm and the
retention time for pleuromutilin was ∼6min. During each run
a pure pleuromutilin standard of 1 mg/ml was used as a control.
Titres were quantified by using a dilution curve based on a range
of pleuromutilin standards (Supplementary Figure 7).
PEG-Mediated Transformation of C. passeckerianus
Protoplasts
C. passeckerianus protoplasts were prepared and transformations
were carried out as described previously (Kilaru et al., 2009).
48 h after the transformation, transformants were selected by
the addition of a 5ml PDAS (PDA plus 0.6M sucrose, pH 6.5)
overlay containing 600µg/ml hygromycin B (Duchefa) to the
regeneration agar (PDAS) plates. Once transformants appeared
(1–2 weeks), they were individually subcultured onto PDA plates
containing 50µg/ml hygromycin B.
S. cerevisiae Transformation
The S. cerevisiae transformation protocol was modified from
Raymond et al. (1999). 50ml of YPD was inoculated with a S.
cerevisiae overnight starter culture and incubated at 30◦C for 5 h
with 230 rpm shaking. Cells were harvested by centrifugation
(2,200 × g for 5min), washed once with SDW and resuspended
in 300 µl SDW. To 50 µl of these cells, 50 µl of denatured
(heated to 95◦C for 2min) salmon sperm DNA (2 µg/µl), and
approximately 1µg of transforming DNAwere added andmixed.
272µL Lithium acetate / PEG premix [240µl 50% PEG 4000 (w/v
in H2O) and 32µL 1M Lithium acetate] was added, mixed gently
and incubated at 30◦C for 30min. The cells were heat shocked
at 45◦C for 15min, pelleted by centrifugation at 2,000 rpm for
2min, and resuspended in 200µl H2Obefore plating out on yeast
synthetic drop out medium (YSDOM).
Yeast Recombination
Plasmids were constructed using yeast homologous
recombination. To achieve this, S. cerevisiae was transformed
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with equal molar amounts of a linearised backbone and the
fragments to be recombined (typically 20–200 ng). Fragments
were amplified using compound primers containing tails with
homology to the backbone or neighboring fragment, to allow
for homologous recombination. The resulting plasmids were
extracted from S. cerevisiae using the ZymoprepTM Yeast Plasmid
Miniprep I kit, according to the manufacturer’s instructions
and 5 µl was transformed into E. coli for plasmid rescue and
propagation (see below).
E. coli Transformations
The preparation of chemically competent DH5-α E. coli cells was
based on that described by Nishimura et al. (1990). An overnight
liquid culture DH5-α was used to inoculate 50ml medium A (LB
with 10mM MgSO4.7H2O, 0.2% glucose) which was incubated
in an orbital shaker at 37◦C, 225 rpm, until the culture reached
mid-logarithmic phase (∼2.5 h). Following 10min incubation
on ice, the cells were harvested at 1,500 × g for 10min at
4◦C and resuspended in ice-cold medium A (0.5ml). 2.5ml of
storage solution B (LB supplemented with 36% glycerol, 12%
PEG 7,500 and 12mMMgSO4.7H2O; filter sterilized) was added
and mixed gently. Cells were divided into 100 µl aliquots and
stored at−80◦C.
For plasmid construction, 5 µl of yeast plasmid extractions
was added to 100 µl of chemically competent DH5-α cells and
was incubated on ice for 30 mins. The cells were heat shocked
in a 42◦C water bath for 45 s and then cooled on ice for
2min. 1ml of LB was added and the cells were incubated at
37◦C with 230 rpm for 30min before plating out on LBA with
appropriate antibiotics.
Construction of the cprp Silencing Construct
Primers cprp-antisense-F and cprp-antisense-R were used to
amplify the cprp antisense fragment from a cDNA clone
(cp_cgc_19_E04). This produced a 1,033 bp product (plus 60 bp
of compound tails introduced by the primers) which included
the 843 bp coding sequence for cprp, a 42 bp section of the
5′ UTR and the entire 148 bp 3′ UTR. Plasmid pYES-hph-
CBXgene (Bailey et al., 2016) was digested with XhoI and SacI
to remove the CBX gene, and the cprp antisense fragment was
recombined into the CBX cassette in the antisense orientation
using yeast homologous recombination. This placed the cprp
antisense fragment under the control of the constitutive GpdII
promoter. The resulting plasmid was named pYES-hph-cprpAS.
Construction of Complementation Plasmids
Constructs for the complementation of a ddr48 mutant strain
were all constructed using the yeast expression vector; pYES2-19.
pYES2-DDR48
The entire open reading frame of ddr48 plus 20 bp of the 5′ UTR,
was amplified from S. cerevisiae strain BY4742 using primers
HindIII_DDR48F andXbaI_DDR48R. The resulting product was
cloned in pJET1.2, sequenced, and confirmed as being identical to
the ddr48 sequence within the genome sequence for S. cerevisiae
strain S288C, the strain from which BY4742 was derived. Ddr48
was then excised from pJET1.2-DDR48 using the restriction
FIGURE 7 | Construction of pYES-hph-cprpGFP.
enzymesHindIII and XbaI and ligated into pYES2-19, producing
the plasmid pYES2-DDR48.
pYES2-CpcDNA and pYES2-CpgDNA
To construct pYES2-CpcDNA, the primers HindIII_DDR48-
cprpF and XbaI_cprpR were used to amplify the coding sequence
of cprp from a cDNA clone (cp_cgc_19_E04) of C. passeckerianus
cDNA library. Primer HindIII_DDR48-cprpF contains 20 bp of
the ddr48 5′ UTR from S. cerevisiae, to improve transcription
in yeast. The resulting PCR product was cloned into pJET2.1,
sequenced, digested out using HindIII and XbaI, and ligated
into pYES2.
pYES2-CpcDNA was constructed exactly as above but rather
than using a cDNA clone as the template for amplification of
cprp coding sequence, the entire cprp gene fromC. passeckerianus
genomic DNA was amplified using primers HindIII_DDR48-
cprpF and XbaI_cprpR.
Construction of the cprp-GFP Fusion Cassette
To identify the promoter region for Cprp, the genomic region
upstream was annotated. A highly conserved gene was identified
1,050 bp upstream of the cprp start codon which encodes
a 3-hydroxyanthranilate 3,4-dioxygenase. As 1 kb is typically
accepted as a suitable length to contain a fungal promoter,
and it is unlikely that the promoter region extends into the
coding region of the adjacent gene, this region was taken to be
sufficient to drive expression. A likely TATA box (TATAAAA)
was identified 101 bp upstream of the cprp start codon.
Yeast homologous recombination was used to build the
desired cprp-GFP fusion cassette and the strategy is summarized
in Figure 7. Compound primers cprp-fusion-F and cprp-fusion-
R were used to amplify the entire promoter region and cprpORF.
cprp-fusion-F was designed to bind to the 20 bp at the 3′ end
of the adjacent gene to ensure the entire intergenic region was
amplified and to avoid any polymorphisms within the promoter
region. To allow for recombination, the 5′ end of this primer
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consisted of the 30 bp upstream of the GpdII promoter in the
plasmid pYES-hph-CBXgene so that during yeast recombination
the promoter region of cprp would replace the GpdII promoter.
cprp-fusion-R consists of the last 20 bp of the cprp ORF, minus
the stop codon and the first 30 bp of the ORF for GFP so that
once recombined, the GFP start codon would replace the cprp
stop codon giving an in-frame fusion. GFP was amplified from
plasmid p004iGM3 (Burns et al., 2005) using the primers GFP-
cprpfusion-F and GFP-cprpfusion-R. These are also compound
primers. GFP-cprpfusion-F binds to the first 20 bp of the gfp
ORF, adding the last 30 bp of cprp (minus the stop codon) to
the 5′ end of the product. The reverse primer was designed to
bind to the last 20 bp of the gfp ORF, including the stop codon,
adding the first 30 bp of the TrpC terminator to the 3′ end of
the amplified product. This was to allow gfp to recombine into
pYES-hph-CBXgene with the gfp stop codon followed by the
TrpC terminator.
Plasmid Purification and Sequencing
Qiagen plasmid preparation kits were used for all plasmid DNA
purification. For sequencing and PCR, 5ml of LB was inoculated
with a single bacterial colony and incubated overnight followed
by an extraction using the Qiagen Mini kit according to the
manufacturer’s instructions. For PEG-mediated transformations
large quantites of very clean DNA were required and the
Qiagen Midi Kit was used with 50ml of overnight culture,
again according to the manufacturer’s instructions. Single-
pass sequencing was used to confirm the sequences of novel




4 µg of total RNA was denatured for each sample, separated
on a 0.8% agarose gel and transferred onto Hounds-N nylon
membrane (GS Healthcare) overnight by capillary action. RNA
was fixed to the membrane by UV crosslinking using a UVP
CL-1000 cross-linker at 1,200 kjoules.cm−1.
Hybridisation
The membrane was pre-wetted in SDW, followed by 5 × SSC
then prehybridised in 50ml Church buffer at 65◦C for at least
4 h with slight shaking. After this time the buffer was discarded
and replaced with 20ml of fresh Church buffer. A cprp probe
of 301 bp was generated by PCR using cprp-Probe-F and cprp-
Probe-R and labeled with [α-32P]dCTP using the Ready-To-
Go labeling kit (Amersham Pharmacia Biotech). The probes
were then cleaned using illustra ProbeQuantTM Micro Columns
(GE Healthcare) according to the manufacturer’s protocol. The
labeled probe was denatured at 95◦C for 2min, cooled on ice for
2min and added to the membrane. Hybridisation was carried out
with slight agitation at 65◦C for∼16 h.
Washing and Autoradiography
After overnight hybridization the membranes were washed at
65◦C in a succession of buffers. This consisted of rinsing the
membrane in 2 × SSC + 0.1% SDS then soaking in 2 × SSC
+ 0.1% SDS with agitation for 5min. This was then repeated
with 1 × SSC + 0.1% SDS. During washing the membrane was
monitored with a Geiger counter until the rate was ∼50–100
counts per second. If counts remained high using the above
buffers, 0.5 × SSC + 0.1% SDS and 0.1 × SSC + 0.1% SDS
would be used. Washed membranes were placed RNA side
down on saran wrap and excess solution was blotted away
using filter paper. The membrane was then wrapped in the
saran film and placed in a radiography cassette and exposed
to autoradiography film at −80◦C overnight. The radiography
cassette was allowed to warm to room temperature to minimize
static. The autoradiograph film was then placed in developing
fluid for 5min, rinsed in water and placed in fixing fluid for
5min. After a final wash in water, the film was air dried.
Stock Solutions
The following solutions were used in Northern analysis.
20 X SSC: 175.3 g/L NaCl, 88.2 g/L sodium citrate - pH 7.
Diluted with DEPC treated SDW to make 0.5 x, 2 x, 5 x, and 10
x SSC.
Church buffer: 200ml phosphate buffer (171ml of 141.96 g/L
Na2HPO4 and 79ml of 119.98 g/L NaH2PO4 - pH 7.2), 700ml
10 % SDS, 2ml of 0.5M EDTA (pH 8). Made up to final volume
of 1 L.
S. cerevisiae Phenotypic Screening
Strain Y10000 (‘WT’) vs. Y16748 (1ddr48)
Mutation rates, as measured by the spontaneous resistance to
canavanine, were studied exactly as previously described by
Treger and McEntee (1990). Responses to osmotic stress were
tested using both agar spotting assays and growth rate in
liquid cultures. For agar spotting assays, cultures were incubated
overnight in liquid YPD medium, and diluted to OD640 = 1
with fresh medium. Drop tests were performed by spotting
5 µl of serially diluted cell suspension onto YPD Agar ± 1M
NaCl. To measure growth rates in liquid cultures, strains were
grown in YPD overnight to saturation. The optical density of
these starter cultures was checked and normalized to ensure
equal inoculum. To ensure that varied cell morphology did not
impact estimations of cell numbers, a haemocytometer was also
used to check the cell concentration which was found to be
∼3.1 × 108 for both strains. 50 µl of the starter culture was
then used to inoculate 5ml volumes of fresh YPD containing
a variety of NaCl concentrations and the optical density of the
cultures was recorded after 16 h. To account for any difference in
growth rate between the wild-type and mutant strain, the optical
densities were calculated as a percentage of YPD cultures with no
additional NaCl.
DDR48 and Cprp Overexpression Strains
Each strain was grown to saturation overnight in YSDOM.
The optical density of these starter cultures was checked and
normalized to ensure equal inoculum. To ensure that varied
cell morphology did not impact estimations of cell numbers, a
haemocytometer was also used to check the cell concentration
which was found to be∼3.1× 108. 50µl of the starter culture was
used to inoculate 5ml of fresh YSDOM-G (a medium containing
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galactose to induce expression from the pGAL1 promoter) with
either 0M or 0.5M NaCl concentrations. After ∼16 h the optical
density of each culture was recorded.
Microscopy
Haemocytometry and GFP detection were carried out using a
Leica DMLB microscope, with GFP screening carried out with
excitation filters at 450–490 nm, dichroic filter at 510 nm and
emission filter at 515 nm.
Confocal microscopy was carried out using the Leica
SP5-AOBS confocal laser scanning microscope equipped
with a 100 mW Ar laser, attached to a Leica DM I6000
inverted epifluorescence microscope. The 488 Argon
(blue) laser line and I3 filter set were used for detection
of GFP.
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